TKNO
Price
$6.34
Change
+$0.15 (+2.42%)
Updated
Oct 1, 04:59 PM (EDT)
Capitalization
340.89M
34 days until earnings call
VTRS
Price
$10.10
Change
+$0.20 (+2.02%)
Updated
Oct 1, 04:59 PM (EDT)
Capitalization
11.54B
39 days until earnings call
Interact to see
Advertisement

TKNO vs VTRS

Header iconTKNO vs VTRS Comparison
Open Charts TKNO vs VTRSBanner chart's image
Alpha Teknova
Price$6.34
Change+$0.15 (+2.42%)
Volume$4.16K
Capitalization340.89M
Viatris
Price$10.10
Change+$0.20 (+2.02%)
Volume$149.51K
Capitalization11.54B
TKNO vs VTRS Comparison Chart in %
Loading...
TKNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TKNO vs. VTRS commentary
Oct 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TKNO is a Buy and VTRS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 02, 2025
Stock price -- (TKNO: $6.19 vs. VTRS: $9.90)
Brand notoriety: TKNO and VTRS are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: TKNO: 101% vs. VTRS: 89%
Market capitalization -- TKNO: $340.89M vs. VTRS: $11.54B
TKNO [@Pharmaceuticals: Generic] is valued at $340.89M. VTRS’s [@Pharmaceuticals: Generic] market capitalization is $11.54B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $65.13B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TKNO’s FA Score shows that 0 FA rating(s) are green whileVTRS’s FA Score has 2 green FA rating(s).

  • TKNO’s FA Score: 0 green, 5 red.
  • VTRS’s FA Score: 2 green, 3 red.
According to our system of comparison, VTRS is a better buy in the long-term than TKNO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TKNO’s TA Score shows that 5 TA indicator(s) are bullish while VTRS’s TA Score has 7 bullish TA indicator(s).

  • TKNO’s TA Score: 5 bullish, 5 bearish.
  • VTRS’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, VTRS is a better buy in the short-term than TKNO.

Price Growth

TKNO (@Pharmaceuticals: Generic) experienced а +19.73% price change this week, while VTRS (@Pharmaceuticals: Generic) price change was +3.12% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.59%. For the same industry, the average monthly price growth was +38.73%, and the average quarterly price growth was +90.63%.

Reported Earning Dates

TKNO is expected to report earnings on Nov 05, 2025.

VTRS is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.59% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTRS($11.5B) has a higher market cap than TKNO($341M). VTRS YTD gains are higher at: -17.400 vs. TKNO (-25.868). TKNO has higher annual earnings (EBITDA): -14.44M vs. VTRS (-493.3M). VTRS has more cash in the bank: 809M vs. TKNO (24M). TKNO has less debt than VTRS: TKNO (29M) vs VTRS (14.8B). VTRS has higher revenues than TKNO: VTRS (14.1B) vs TKNO (38.9M).
TKNOVTRSTKNO / VTRS
Capitalization341M11.5B3%
EBITDA-14.44M-493.3M3%
Gain YTD-25.868-17.400149%
P/E RatioN/A236.20-
Revenue38.9M14.1B0%
Total Cash24M809M3%
Total Debt29M14.8B0%
FUNDAMENTALS RATINGS
VTRS: Fundamental Ratings
VTRS
OUTLOOK RATING
1..100
72
VALUATION
overvalued / fair valued / undervalued
1..100
11
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
TKNOVTRS
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
65%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
69%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
66%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
64%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
62%
Advances
ODDS (%)
Bullish Trend 6 days ago
86%
Bullish Trend 2 days ago
68%
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
Bearish Trend 9 days ago
65%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
62%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
TKNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
JEQ7.880.05
+0.64%
abrdn Japan Equity Fund
FJAN50.150.10
+0.20%
FT Vest US Equity Buffer ETF Jan
FEMB29.340.02
+0.07%
First Trust Emerging Mkts Lcl Ccy Bd ETF
MAYP30.21N/A
N/A
PGIM S&P 500 Buffer 12 ETF - May
ODOT4.50N/A
N/A
Osprey Polkadot Trust

TKNO and

Correlation & Price change

A.I.dvisor tells us that TKNO and HROW have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TKNO and HROW's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TKNO
1D Price
Change %
TKNO100%
+9.56%
HROW - TKNO
33%
Poorly correlated
-0.45%
AMRX - TKNO
30%
Poorly correlated
+1.42%
NBIX - TKNO
29%
Poorly correlated
+0.08%
EBS - TKNO
28%
Poorly correlated
-1.34%
VTRS - TKNO
27%
Poorly correlated
+2.91%
More

VTRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTRS has been loosely correlated with ELAN. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if VTRS jumps, then ELAN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTRS
1D Price
Change %
VTRS100%
+2.91%
ELAN - VTRS
53%
Loosely correlated
+2.70%
ZTS - VTRS
48%
Loosely correlated
+2.28%
AMRX - VTRS
44%
Loosely correlated
+1.42%
EBS - VTRS
40%
Loosely correlated
-1.34%
COLL - VTRS
39%
Loosely correlated
+1.21%
More